URGN

UroGen Pharma is a biopharmaceutical company developing treatments for urological cancers and diseases. The company specializes in RTGel technology, a proprietary sustained-release hydrogel formulation that enables prolonged exposure of urological tissues to therapeutic agents. UroGen focuses on bladder and upper urinary tract cancers.